
Nanologica
NICA | ST
Overview
Corporate Details
- ISIN(s):
- SE0005454873 (+2 more)
- LEI:
- 54930017L41C7P87LP22
- Country:
- Sweden
- Address:
- Forskargatan 20 G, 151 36 Södertälje
- Website:
- https://nanologica.com/
- Sector:
- Health Care
- Industry:
- Life Sciences Tools & Services
Description
Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface properties of silica particles, creating opportunities to develop unique products. The company’s vision is to contribute to better and cheaper medicine through porous silica. In Chromatography, the aim is to make diabetes drugs and other peptide-based drugs available to more patients by providing products that can lower the production costs at the manufacturers. In Drug Development, the company’s platform for inhalation is developed to give patients with severe lung diseases access to new or improved treatments.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-30 11:00 |
Regulatory News Service
Antal aktier och röster i Nanologica AB (publ)
|
Swedish | 44.5 KB | |
2025-06-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Number of Shares and Votes in Nanologica AB (publ)
|
English | 43.9 KB | |
2025-06-13 10:34 |
Takeover Announcement Report
UTTALANDE FRÅN STYRELSEN I NANOLOGICA AB (PUBL) MED ANLEDNING AV BUDPLIKTSERBJU…
|
Swedish | 51.9 KB | |
2025-06-13 10:34 |
Takeover Announcement Report
STATEMENT FROM THE BOARD OF DIRECTORS OF NANOLOGICA AB (PUBL) REGARDING THE MAN…
|
English | 50.7 KB | |
2025-06-12 08:14 |
Regulatory News Service
NANOLOGICA AB (PUBL) TAR ORDER OM CA 1,3 MSEK FRÅN NY KUND I USA
|
Swedish | 48.9 KB | |
2025-06-12 08:14 |
Regulatory News Service
NANOLOGICA AB (PUBL) RECEIVES ORDER OF APPX. SEK 1.3 MILLION FROM NEW CUSTOMER …
|
English | 48.6 KB | |
2025-05-23 16:41 |
Share Issue/Capital Change
Nanologica AB (publ) meddelar utfall av inlösen av teckningsoptioner av serie T…
|
Swedish | 41.2 KB | |
2025-05-23 16:41 |
Share Issue/Capital Change
Nanologica AB (publ) Announces the Outcome of the Exercise of Warrants of Serie…
|
English | 40.5 KB | |
2025-05-23 07:36 |
Takeover Announcement Report
Kommentar från styrelsen i Nanologica AB (publ) angående budpliktsbud från Fler…
|
Swedish | 48.3 KB | |
2025-05-23 07:36 |
Takeover Announcement Report
Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from…
|
English | 48.3 KB | |
2025-05-22 14:54 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from the AGM 2025 Nanologica AB (publ)
|
English | 48.0 KB | |
2025-05-22 14:54 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké årsstämma 2025 Nanologica AB (publ)
|
Swedish | 47.8 KB | |
2025-04-23 07:06 |
Regulatory News Service
Nanologica AB Receives Order Worth USD 180,000 from New Customer in China
|
English | 46.7 KB | |
2025-04-23 07:06 |
Regulatory News Service
Nanologica AB tar order om 180 000 USD från ny kund i Kina
|
Swedish | 47.0 KB | |
2025-02-14 08:10 |
Earnings Release
|
Swedish | 843.1 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2021-06-08 | Andreas Bhagwani | Other | Other | 82,566 | 767,863.80 SEK |
2021-06-08 | Andreas Bhagwani | Other | Buy | 82,566 | 503,652.60 SEK |
2021-06-08 | Andreas Bhagwani | Other | Buy | 145,000 | 1,348,500.00 SEK |
2021-06-08 | Tomas Kramar | Other | Buy | 20,000 | 300,000.00 SEK |
2021-06-08 | Andreas Bhagwani | Other | Sell | 68,000 | 1,020,000.00 SEK |
2021-06-08 | Investmentaktiebolaget Akkumula | Other | Buy | 10,000 | 150,000.00 SEK |
2021-06-07 | Mattias Bengtsson | Other | Buy | 13,000 | 195,000.00 SEK |
2021-06-04 | Andreas Bhagwani | Other | Sell | 110,000 | 1,650,000.00 SEK |
2021-06-04 | Andreas Bhagwani | Other | Sell | 145,000 | 2,175,000.00 SEK |
2020-12-03 | Adam Feiler | Other | Other | 14,400 | 133,920.00 SEK |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
|
BICO Group | Sweden | BICO | |
CERDIOS SE | Liechtenstein | N/A | ||
![]() |
Eurofins Scientific SE | Luxembourg | ESF0 | |
![]() |
GREENROC STRATEGIC MATERIALS PLC | United Kingdom | GROC | |
Mainz BioMed N.V. | Germany | N/A | ||
MaxCyte, Inc. | United States of America | N/A | ||
![]() |
MICHELMERSH BRICK HOLDINGS PLC | United Kingdom | MBH | |
Ondine Biomedical Inc. | Canada | N/A | ||
|
Royal DSM N.V. | Netherlands (Kingdom of the) | DSM | |
![]() |
SCIENCE IN SPORT PLC | United Kingdom | SIS |